The device company, however, experienced a slight decline in revenue from the fourth quarter of 2010, which sat at approximately $129.3 million. According to the news release, the sequential decrease was driven in part by approximately $4 million in seasonal capital purchases and back royalties related to a settlement in 4Q 2010.
Read the company news release about NuVasive’s financial results.
Related Articles on Device Company Financial Results:
InVivo Therapeutics Reports $1.28M Net Loss in Q1
Bacterin Reports $6M in Q1 Revenue, 119% Increase
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
